Search

everythinglearnresearchcommunity

for

Search:↓

Cosmos caudatus extract is as effective as finasteride for treating benign prostatic hyperplasia without its side effects.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Topical cyclosporin-A is recommended for severe alopecia areata.

CAM offers natural hair care solutions that may improve hair health and growth with fewer side effects.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Trichoscopy helps accurately diagnose temporal triangular alopecia.

Patients with central centrifugal cicatricial alopecia often have higher rates of metabolic, autoimmune, and atopic conditions, as well as anxiety and depression.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Tofacitinib might be used to treat hair loss.

The protein CTCF is essential for skin development, maintaining hair follicles, and preventing inflammation.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

TCDD speeds up skin barrier formation by increasing certain gene expressions.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Chlorinated compounds like TCDD can cause skin issues and chloracne by affecting cell behavior.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Dermatoscopy can help diagnose CCCA without visible hair loss, offering a less invasive option than biopsy.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Allergens might contribute to CCCA, so avoiding them could help manage the condition.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Some CAM therapies help with pediatric atopic dermatitis, but more research is needed.